SV Investment Corp is a Korea-based venture capital (VC) firm principally engaged in the investment in small to medium enterprises (SMEs). The Company principally engaged in the investment in SMEs and venture companies, overseas investment, establishment and management of business incubation centers, as well as formation of private equity funds (PEF). In addition, the Company also provides initial public offering (IPO), merger and acquisitions (M&A), and secondary support services.

Employees

Sector

Investment Management & Fund Operators

More about the company

Quotes

Date	Price	Change	Volume
01/09/26	KRW 2,265.00	-2.37%	600,713
31/08/26	KRW 2,320.00	-5.69%	1,287,478
28/08/26	KRW 2,460.00	-2.19%	1,455,786
27/08/26	KRW 2,515.00	+3.50%	13,456,563
26/08/26	KRW 2,430.00	-2.21%	2,117,646

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 01/09/2026			5-day change	1st Jan Change
2,265.00 ^KRW	-2.37%		-13.71%	+32.38%

20/08	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
03/07	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI

Market Cap	136B 99.16M 85.54M 80.5M 73.42M 138M 9.41B 139M 954M 370M 4.78B 372M 364M 15.92B	P/E 2025	-13.1x	P/E 2026	-205x
Enterprise Value	143B 104M 90.05M 84.74M 77.29M 145M 9.91B 146M 1B 390M 5.04B 392M 383M 16.76B	EV / Sales 2025	3.42x	EV / Sales 2026	9.89x
Free-Float	75.22%	Yield 2025 *	-	Yield 2026	-

20/08	KaliVir Immunotherapeutics, Inc. announced that it has received $25 million in funding from Premier Partners, LLC, Quad Investment Management Corp., Nextrans, Flexus Partners Co., Ltd., SV Investment Corporation, Company K Partners Limited	CI
03/07	LinqAlpha Inc. announced that it has received $21.99996 million in funding from a group of investors	CI
18/06	SV Investment Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
30/05	XCENA Inc. announced that it has received KRW 202 billion in funding from a group of investors	CI
28/05	ASTEROMORPH announced that it has received KRW 47 billion in funding from a group of investors	CI
21/05	LinqAlpha Inc. announced that it expects to receive $19.999992 million in funding	CI
14/05	SV Investment Corporation announces Annual dividend, payable on July 16, 2026	CI
14/04	XCENA Inc. announced that it expects to receive KRW 150 billion in funding from a group of investors	CI
26/02	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
13/02	SV Investment Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
14/11	SV Investment Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
28/10/25	PineTree Therapeutics, Inc. announced that it has received $47.000004 million in funding from a group of investors	CI
22/08/25	PineTree Therapeutics, Inc. announced that it expects to receive $48.00006 million in funding	CI

1 day	-2.37%
1 week	-13.71%
Current month	-2.37%
1 month	+28.91%
3 months	-15.17%
6 months	-42.80%
Current year	+32.38%

SV Investment Corporation Stock

Stocks

A289080

KR7289080004

Investment Management & Fund Operators

Valuation : SV Investment Corporation

Chart: SV Investment Corporation

Latest news : SV Investment Corporation

Quotes and Performance

Price Extremes

Managers and Directors : SV Investment Corporation

Venture Capital

Financials

Company Profile

Quotes

1 week	2,255	2,840
1 month	1,725	2,840
Current year	1,439	5,030
1 year	1,439	5,030
3 years	1,156	5,030
5 years	1,156	5,030
10 years	1,156	8,570

Manager	Title	Age	Since
Seong-Ho Park CEO	Chief Executive Officer	57	-
Won-Ho Hong CEO	Chief Executive Officer	61	30/09/2019
Ji-Hwa Ryu PRN	Corporate Officer/Principal	56	30/06/2023

Director	Title	Age	Since
Won-Ho Hong BRD	Director/Board Member	61	30/09/2019
Seong-Ho Park BRD	Director/Board Member	57	-
Ji-Hwa Ryu BRD	Director/Board Member	56	30/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SV INVESTMENT CORPORATION	-2.37%	-13.71%	+29.21%	+15.03%	102M
BB BIOTECH AG	-0.72%	0.00%	+73.44%	+35.20%	3.81B
HERCULES CAPITAL, INC.	+0.17%	+0.97%	-9.48%	+7.42%	3.26B
HBM HEALTHCARE INVESTMENTS AG	+0.86%	-0.42%	+33.96%	+32.01%	1.91B
MOLTEN VENTURES PLC	-3.89%	-1.09%	+89.91%	+179.17%	1.51B
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	730M
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	-2.50%	-4.22%	+136.55%	+208.52%	605M
BRITISH SMALLER COMPANIES VCT PLC	0.00%	0.00%	-3.33%	-7.05%	410M
OCTOPUS TITAN VCT PLC	0.00%	0.00%	-40.68%	-75.18%	391M
PEMBROKE VCT PLC	0.00%	0.00%	-0.53%	-13.02%	371M
Average	-0.84%	-0.27%	+30.73%	+37.51%	1.31B
Weighted average by Cap.	-0.63%	+0.89%	+39.46%	+43.98%

	2025	2026
Net sales	19.98B 14.55M 12.55M 11.81M 10.77M 20.2M 1.38B 20.34M 140M 54.34M 702M 54.6M 53.4M 2.34B	20.52B 14.94M 12.88M 12.13M 11.06M 20.74M 1.42B 20.89M 144M 55.79M 721M 56.05M 54.82M 2.4B
Net income	-5.23B -3.81M -3.29M -3.09M -2.82M -5.29M -361M -5.33M -36.63M -14.23M -184M -14.29M -13.98M -612M	-1B -729K -629K -592K -540K -1.01M -69.17M -1.02M -7.01M -2.72M -35.16M -2.74M -2.68M -117M
Net Debt	-1.04B -758K -654K -615K -561K -1.05M -71.9M -1.06M -7.29M -2.83M -36.55M -2.84M -2.78M -122M	7.18B 5.23M 4.51M 4.24M 3.87M 7.26M 496M 7.31M 50.26M 19.52M 252M 19.61M 19.18M 839M